期刊文献+

原发性肝癌患者可溶性Tie-2对血管新生的作用 被引量:1

Role of sTie-2 in angiogenesis of primary hepatic carcinoma
下载PDF
导出
摘要 【目的】通过检测血清中sTie-2的表达,研究可溶性Tie-2与原发性肝癌血管新生的相关性,探讨可溶性Tie-2在原发性肝癌血管新生中的作用。【方法】采用夹心ELISA法检测32例原发性肝癌患者和15例肝硬化患者术前血清中可溶性Tie-2以及15例健康献血员血清中可溶性Tie-2的表达水平。采用免疫组化技术S-P法,检测肝癌组织、肝硬化组织和肝破裂之正常肝组织中Ang-2和Tie-2的表达。【结果】肝癌患者术前血清中sTie-2比肝硬化和健康鲜血员血清中sTie-2明显增高,而肝硬化与健康献血员血清中sTie-2差异无显著性。可溶性Tie-2在原发性肝癌患者血清中表达明显上调。【结论】可溶性Tie-2在原发性肝癌血管新生中起重要作用s。 【Objective】 Through sTie-2 is detected in the preoperative serums of primary hepatic carcinoma(PHC) and hepatic cirrhosis(HC) and serums of healthy blood donor.To study correlation soluble Tie-2(sTie-2) and PHC.To investigate the role of soluble Tie-2 in angiogenesis of PHC.【Methods】 Expression levels were detected in preoperative serums of HC and PHC were obtained from patients with hepatic cirrhosis or primary hepatic carcinoma by ELISA technique,and serums of healthy blood donor act as control group.Through streptavidin-biotin-peroxidase complex technique(S-P technique) of immunohistochemistry,Ang-2 and Tie-2 were detected in hepatoma tissues,tissues of HC and normal tissues.【Results】 The expression levels of sTie-2 in preoperative serum of primary hepatic carcinoma are higher than those of hepatic cirrhosis and healthy persons.The expression levels of sTie-2 between hepatic cirrhosis and healthy persons are no significance in statistics.Soluble Tie-2 were significantly up-regulated in preoperative serums of PHC compare to preoperative serums of PHC and serums of healthy blood donor.【Conclusion】 Soluble Tie-2 may play critical role in promoting tumor angiogenesis of PHC,the expression levels of sTie-2 in preoperative serum of PHC offer a new index for clinical screening and early diagnose of PHC.
出处 《武警医学院学报》 CAS 2011年第1期7-9,共3页 Acta Academiae Medicinae CPAPF
基金 天津市应用基础研究计划面上基金(05YFJMJC08100)
关键词 原发性肝癌 血管新生 可溶性Tie-2 Primary hepatic carcinoma Angiogenesis Soluble Tie-2
  • 相关文献

参考文献6

  • 1Hanahan D. Signaling vascular morphogenesis and maintenance [J]. Science, 1997, 277(5322): 48-50.
  • 2焦辉,郭春良,王宏.血管生成素-2/受体-2在肝癌血管新生中的作用[J].中国肿瘤临床,2008,35(11):644-647. 被引量:3
  • 3Baron AT, Lafky JM, Boardman CH, et al. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer, Cancer Epidemiol [J]. Biomarkers Prev, 1999, 8 (2): 129-137.
  • 4Heaney ML, Golde DW. Soluble cytokine receptors[J]. Blood, 1996, 87(3): 847-857.
  • 5Harris Al, Reusch P, Barleon B, et al. Soluble Tie2 and Fltl extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy[J]. Clin Cancer Res, 2001, 7(7): 1992- 1997.
  • 6Lin P, Polverini P, Dewhirst M, et al. Inhibition of tumor angiogenesis using a soluble establishes a role for Tie2 in pathologic vascular growth[J]. J Clin Invest, 1997, 100(8): 2072- 2078.

二级参考文献10

  • 1赵志成,郑树森,万云乐,贾长库,李锦军,顾建人,郭炳麟.促血管生成因子及受体在肝癌生长中的作用[J].中华肿瘤杂志,2004,26(8):472-475. 被引量:10
  • 2谷金宇,吕雪莹,李大林,任欢.缺氧诱导结直肠癌细胞Ang-2的表达[J].中国肿瘤临床,2006,33(14):802-804. 被引量:6
  • 3Etoh T, Iniue H, Tanaka SH, et al. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases[]]. Cancer Res, 2001, 61: 2145-2153.
  • 4He J, Gu D, Wu X, et al. Major causes of death among men and women in China[J]. N Engl Med, 2005, 353 (11) : 1124-1134.
  • 5vajkoczy P, Farhadi M, Ganman A, et al. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2[J]. J Chin invest, 2002, 109(6): 777-780.
  • 6Cho CH,Kammerer RA,Lce HJ,et al. Designed angiopoietin-1 variant,COMP-Angl,protects against radiation-induced endothelial cell apoptosis[J]. Proc Natl Acad Sci USA. 2004, 101 (15): 5553-5558.
  • 7Ward NL, Haninec AL, Van SP, et al. Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice [J]. Am J Pathol, 2004, 165(3): 889-899.
  • 8Stoeltzing O, Ahmad Sa, Liu W, et al. Angiopoietin-1 inhibits vascular permeability, angiogen- esis, and growth of hepatic colon cancer tumors[J]. Cancer Res. 2003, 63(12): 3370-3377.
  • 9Tanaka S, Sugimachi K, Yamashita Y, et al. Angiogenic switch as a molecular target of malignant tumors[J]. J Gastroemerol. 2003, 38(15): 93-97.
  • 10刘学强,万恒荣,陈海生,彭林.促血管生成素在原位种植肝癌组织中的表达及其意义[J].中国普通外科杂志,2004,13(3):196-198. 被引量:5

共引文献2

同被引文献6

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部